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ENHANCEMENT OF PASTEURELLA HAEMOLYTICA 
A 1 LEUKOTOXIN ACTIVITY BY BOVINE 
SERUM ALBUMIN 
ABSTRACT 
Growth of Pasteurella haemolytica A 1 in media containing fetal 
bovine serum has been observed to enhance leukotoxin (LKT) activity, but 
the mechanism of this increase is not understood. We found that bovine 
serum albumin in the absence of other serum components also enhances 
LKT activity. During the logarithmic growth phase, LKT activity was 
30,700 ± 12,900 Toxic Units (TU)/ml for P. haemolytica grown in RPM I 
medium containing 0. 5% bovine serum albumin (BSA) (BSA-LKT), 
compared to 120 ± 40 TU/ml in medium containing RPMI alone (RPMI-
LKT). In other experiments, addition of 0.5% BSA to RPMI-LKT culture fil-
trate (RPMI-LKT/BSA) resulted in LKT activity intermediate ( 13,000 ± 
1,600 TU/ml) between that of BSA-LKT (55,600 ± 11,500 TU/ml) and 
RPMI-LKT (2,200 ± 900 TU/ml). The activity of RPMI-LKT, BSA-LKT and 
RPMI-LKT /BSA decreased when the toxin preparations were incubated at 
room temperature (25°C) for 2 hours; however, the decrease in RPMI-LKT 
activity was more pronounced. Concentrated toxin from logarithmic growth 
phase RPMI-LKT culture supernatants contained a single LKT activity peak 
(Peak I) on Sephacryl HR-400 which had a K of 0.01 and estimated 
av 
molecular weight > > 669,000. In contrast, gel filtration of concentrated 
toxin from logarithmic growth phase BSA-LKT culture supernatants had 
1 
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three activity peaks with K values of 0.04 (Peak 1), 0.66 (Peak II), and 
av 
0.87 (Peak Ill). Gel filtration of RPMI-LKT/BSA also consisted of Peaks I, II, 
and Ill. Peaks I, II, and Ill contain a prominent 97000 band on SDS-PAGE 
which was identified as LKT by Western blot analysis with an monoclonal 
antibody (MAB) to LKT. The identity of Peaks I, II, and Ill were further 
confirmed as LKT by target cell specificity (lysed bovine lymphoma cells 
and not equine leukocytes) and neutralization with a MAB toP. haemolytica 
LKT. It is concluded that LKT produced in RPMI medium alone is a large 
aggregate which undergoes conformational changes in the presence of BSA 
resulting in at least two additional LKT forms which may be partially dis-
aggregated forms of the large aggregate LKT produced in RPMI. 
INTRODUCTION 
Pasteurella haemolytica biotype A, serotype I, is the most common 
strain of bacteria isolated from cattle with bovine pneumonic pasteurellosis 
(shipping fever pneumonia). This bacterium produces several structural and 
nonstructural components important for production of disease including 
endotoxin, polysaccharide capsule, outer membrane proteins and an exo-
toxin (leukotoxin) {8). 
Leukotoxin, a heat-labile immunogenic exotoxin produced by Pasteu-
rella haemolytica A 1 during its logarithmic growth phase (8), is toxic to 
ruminant leukocytes and may act to impair pulmonary defenses or incite 
undesirable inflammatory reactions (8). Leukotoxin is a member of the 
repeats in toxin (RTX) family of gram negative bacterial cytolysins (23). The 
nucleic acid sequences of the polycistronic gene coding for activation, 
structural, and transport proteins of P. haemolytica LKT and the prototype 
RTX toxin E. coli a-hemolysin are similar, sharing 66, 62, 90.5 and 75.6% 
sequence homology, respectively (11, 17,22). Membe.rs of the RTX family 
injure target cells by the formation of transmembrane pores resulting in 
osmotic lysis (4-7). In addition, at sublytic concentrations, LKT is a potent 
neutrophil modulating agent which can stimulate the release of neutrophil 
oxidative intermediates, preferential release of secondary granule constitu-
ents, and induce cytoskeletal alterations in bovine neutrophils (9). LKT is 
distinguished from other RTX cytolysins by its narrow target cell specificity: 
ruminant leukocytes and platelets {4-7, 15,20). Although the calculated 
molecular weight for LKT, from its gene sequence is 105,000, the primary 
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band identified in culture supernatants of P. haemolytica examined by 50S-
polyacrylamide gel electrophoresis (SDS-PAGE) is a 97,000 protein (3). 
The structure of the native LKT is uncertain, but it appears to be a multimer 
of·this 97,000 protein (3). Molecular weight estimates of the native LKT 
have ranged from 150,000 to > 300,000 (2, 13, 17). 
Growth of P. haemolytica A 1 in medium supplemented with fetal 
bovine serum results in enhanced toxinogenesis ( 12). Based on this 
enhancement of LKT activity by inclusion of nonheme or heme iron binding 
proteins, iron availability was judged important for toxinogenesis (12). We 
also observed that addition of bovine serum albumin (BSA) in the absence 
of other serum components to P. haemolytica culture medium resulted in 
enhanced LKT activity (24). To examine the mechanism for BSA enhance-
ment of toxin activity from P. haemolytica, the molecular weight of LKT 
from P. hrJemolytica grown in media with and without BSA were compared. 
In this report, we also describe a partial· purification procedure with 
ammonium sulfate concentration of the LKT followed by gel filtration 
chromatography, which allowed us to obtain biologically active, partially 
purified toxin. 
MATERIALS AND METHODS 
Preparation of Pasteurella haemolytica A 1 culture supernate leukotox-
in. Brain heart infusion (BHI) agar (Difco Laboratories, Detroit, Ml) plates 
supplemented with 5% bovine blood were inoculated with a stock culture 
of P. haemolytica A 1 (stored in 10% glycerol + BHI broth at -70°C) and 
grown overnight (18 hours) at 37°C, in 5% C02 (12). BHI broth (100 
ml/500 ml Erlenmeyer flask) was inoculated from the blood agar cultures to 
an 00650 of 0.20-0.35, and the bacteria were grown at 37°C with 80 
oscillations/min until the 00650 reached 0.80-1.0. Bacteria were collected 
by centrifugation (Sorvall, GS3 rotor, 8000 rpm) for 20 minutes and resus-
pended in 10 ml of either RPMI-1640 medium (RPMI), pH 7.2 or RPMI, pH 
7.2, containing 0.5% BSA (RPMI-BSA), (Fraction V, bovine serum albumin, 
Sigma Chemical Company, #A-6003). These cultures were used to inocu-
late Erlenmeyer flasks containing either RPMI or RPMI-BSA to an 00650 of 
0.200-0.350. RPMI and RPMI-BSA were buffered with 2.0 g/L of sodium 
bicarbonate (Sigma Chemical Company), and the pH adjusted to 7.0 prior 
to filter sterilization (Nalgene cellulose acetate, 0.2 urn filter); final pH after 
filtration was 7 .2. The pH of the RPM I medium was checked before and 
after addition of BSA, and did not change upon addition of BSA. The total 
volume inoculated was always 20% of the flask capacity, and flask number 
and size were adjusted depending on the quantity of LKT needed; i.e.: (a) 
for gel filtration experiments, 400 ml medium in 2L flasks was inoculated 
with P. haemolytica, and (b) for timed experiments, 5 replicates of each 
type media were inoculated, 100 ml medium in 500ml flasks. Cultures were 
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incubated in an environmental orbital shaker incubator at 37°C, 80 oscilla-
tions/min, and grown to an OD650 of 0.80-1.01 (or for a specific period of 
time). For timed experiments, the supernatant was collected by filtration 
with a 0. 2um cellulose acetate (Nalgene) filter. For gel filtration experi-
ments, the supernatant was collected by centrifugation (Sorvall, GS3 rotor, 
8000 rpm), filtered with a 0.2um cellulose acetate filter and precipitated 
with ammonium sulfate at 50% saturation (313 g/L) (J.T. Baker Chemical 
Company, Phillipsburg, NJ). The precipitate was collected by centrifugation 
(Sorvall, GS3 rotor, 11 ,500 rpm) for 40 minutes, resuspended in 4.0 ml of 
column buffer ( 10 mM Tris, 50 mM NaCI, pH 7 .3), and filtered with a 
0.2 urn cellulose acetate filter. RPMI-LKT for gel filtration was also concen-
trated approximately 40X with a stircell apparatus (Amicon), with a Diaflo 
YM 10 membrane (molecular weight cutoff of 1 0,000), (Amicon, W.R. 
Grace & Co., Danvers, MA). 
Leukotoxin Assay. Bovine lymphoma cells (BL-3 cells, G. Theilen, 
University of California, Davis), used as target cells, were exposed to LKT 
in non-diluted or diluted column fractions or culture filtrate by one of two 
assay formats: (a) in microfuge tubes or 96 well round bottom microtitre 
plates (total assay volume 250 ul), or (b) 96 well round bottom microtitre 
plates (total assay volume 200 ul), and incubated for 2 hours at 37°C in a 
culture incubator. BL-3 cells split 1:1 in fresh media 1 day prior to use in 
assays, were resuspended in RPMI (pH 7.2), and cell concentration was 2 x 
106 BL-3 cells/mi. At the end of the toxin incubation period, test samples 
were then centrifuged (microfuge tubes: Surespin, Helena Laboratories, 
10,000 rpm, 2 minutes; microtitre plates: Sorvall, H 1 OOOB rotor, 1000 
rpm, 10 minutes), and the supernatant assayed for the cytoplasmic 
enzyme, lactate dehydrogenase (LDH) by one of three methods: (a) a 
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chemistry analyzer using a spectrophotometric assay at 340 nm (Centrifu-
chem (Dupont), with a commercial LDH assay kit (LDL-50 1 X concentra-
tion; Sigma Chemical Company), (b) a non-thermally controlled colorimetric 
assay at 490 nm (Vmax, Molecular Devices, 2 minute kinetic assay), using 
2-[4-iodophenyl]-3-[4-nitrophynl]-5 phenyltetrazolium chloride (I NT, Sigma 
Chemical Company #1-8377) 16.7 mg and phenazine methosulfate (PMS, 
Sigma Chemical Company P-9625) 4.3 mg dissolved in 50 ml of LDL-50 1 X 
concentration (Sigma Chemical Company) (15), or (c) a thermometric spec-
trophotometric kinetic assay at 340 nm (Thermomax, Molecular Devices, 2 
minute kinetic run) (LDL-50 2X concentration, Sigma Chemical Company). 
BL-3 cells were incubated with 1% Triton (Triton-X, EM Industries) to 
release 100% of cellular LDH for positive controls. Spontaneous LDH 
release was determined from BL-3 cells incubated with RPMI. Raw data 
was reported as mOD/min for the colorimetric and thermometric spectro-
photometric kinetic assays, and as IU/L for the spectrophotometric assay 
using the chemistry analyzer (gel filtration elution profiles). Raw data was 
converted to Toxic Units (TU) in experiments where quantitation of the LKT 
was necessary (timed experiments). To determine TU, serial dilutions of the 
toxin were incubated with the BL-3 cells, the LDH mOD/minute plotted 
against the reciprocal dilution of the filtrate sample, and the number of TU 
determined by pro bit analysis (21). One TU was defined as the amount of 
LKT required to release 50% of the LDH from 2x106 BL-3 cells/mi. 
P. haemolytica growth and LKT activity. To examine the effect of 
BSA on P. haemolytica growth and LKT production, five cultures of P. 
haemolytica grown in RPMI medium were compared to five cultures grown 
in RPMI-BSA medium. Culture growth was assessed by measuring culture 
turbidity (00650) at 0, 2.5, 6, 12, and 24 hours of incubation. Aliquots of 
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filtered RPMI-LKT and BSA-LKT culture supernatant were assessed for 
cytotoxicity against BL-3 cells by release of LDH. Data were analyzed with 
the student's t-test (22). 
Effect of BSA on RPMI-LKT. To examine the effect of addition of 
BSA on RPMI-LKT, RPMI-LKT and BSA-LKT were prepared as described 
from 2.5 hour bacterial cultures. The culture supernatants were filtered, 
and the RPMI-LKT divided into two equal volumes in 100 ml sterile Pyrex 
bottles. An aliquot of RPMI-LKT from one of the bottles was removed, and 
an equal volume of filter sterilized, concentrated (1 0%) BSA in RPMI was 
added to bring the RPMI-LKT culture filtrate up to 0. 5% BSA (RPMI-
LKT/BSA). An equal volume of the BSA-LKT was placed into a sterile 100 
ml Pyrex bottle, and a volume equal to that removed from the RPMI-LKT 
was removed from the BSA-LKT and the second RPMI-LKT preparations 
and replaced with the same volume of sterile RPMI medium. The BSA-LKT, 
RPMI-LKT and RPMI-LKT/BSA filtrates were incubated at 25°C in an envi-
ronmental shaker incubator at 100 oscillations per minute, and triplicate 
samples from each preparation were assayed for LKT activity after 0, 15, 
30, 60, and 120 minutes of incubation. Time 0 was defined as the time of 
addition of the BSA to the RPMI LKT. Data were analyzed using ANOVA 
and LSD (22). The above experiment was repeated using low endotoxin 
BSA (fraction V powder Albumin, Sigma Chemical Company, #A-9543), 
which contains less than 0.1 ng/mg of protein of detectable endotoxin. 
Gel-filtration chromatography. Ammonium sulfate-precipitated and 
concentrated RPMI-LKT, BSA-LKT or RPMI-LKT/BSA or stircell concentrated 
RPMI-LKT in a volume of 2.5 ml was loaded onto a Pharmacia K26/70 
column packed with Sephacryl HR-400 (Pharmacia). The total bed volume 
of the column was 336.0 mi. Fractions were collected into tared test tubes 
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every 15 minutes with a Pharmacia Helirac, and the mean fraction volume 
calculated for each run. Fractions were eluted with column buffer (1 0 mM 
Tris, 50 mM NaCI, pH 7 .3) at a flow rate of 20 ml/hour. The column was 
calibrated with Tobacco mosaic virus (molecular weight 45,000,000) or 
heat killed Serratia marscesens (void volume), thyroglobulin (669,000), 
ferritin (440,000), catalase (232,000), bovine serum albumin ( 67 ,000), 
carbonic anhydrase (29,000), and ribonuclease A (13,500). The presence 
of LKT in column fractions was detected by immunoblotting and assaying 
for LKT activity. Protein was detected by measuring absorbance of column 
fractions at optical density (OD) 280. Protein content of column fractions 
was measured with the BCA protein assay using a microtitre plate tech-
nique (Pierce Chemical Co.), at OD 540 nm (VMax, Molecular Devices). 
Fractions from Peaks I, II and Ill from BSA-LKT were pooled and 
concentrated by precipitation with 5% trichloroacetic acid (TCA, Sigma 
Chemical Company, #T-6399) (final volume/volume) at 4°C for 30 minutes 
(9). The precipitate was collected by centrifugation (Sorvall, H 1 0008 rotor, 
3600 rpm, 10 minutes), resuspended in electrophoresis sample buffer, and 
the pH of the samples adjusted by addition of 1 % NaOH until the indicator 
dye (bromphenol blue) in the sample buffer turned from yellow to blue 
(approximate pH 7.0-7.2 determined with pH paper). 
Silver stained SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
and western blotting. Column fractions or TCA precipitated samples con-
taining LKT activity were diluted 1:2 in sample buffer (electrophoresis 
sample buffer: 25 ml Tris, pH 6.8, 2 g SDS, 1 0 ml glycerol, 5 ml 2-mercap-
toethanol, and 100 ul of 1% bromophenol blue), denatured by boiling for 
1.5 minutes, and subjected to SDS-PAGE, using a 4% stacking gel and a 
10% resolving gel (18). The resulting bands were demonstrated by a silver 
stain method (25). Duplicate gels were transferred to nitrocellulose 
membranes and LKT detected with an anti-LKT monoclonal antibody (MAB) 
against the 97,000 LKT band (MAB601 and/or MAB605b) obtained from 
Drs. M.J. Gentry and S. Shrikumaran, University of Nebraska) ( 13). Bands 
were identified as previously described (18). The MAB was diluted 1:500, 
the secondary antibody (biotinylated anti-mouse whole molecule lgG, goat 
derived (Amersham International, RPN 1177) diluted 1 :300, and streptavi-
din-biotinylated horseradish peroxidase complex (Amersham International, 
RPN 1051) dilution (to detect the reaction) diluted 1:400, with 1% gelatin 
in tween-phosphate buffered saline, pH 7.5. Bands were demonstrated with 
horseradish peroxidase color developer (Sigma Chemical Company) (18). 
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Target cell specificity assay. Fractions from Peaks I, II, and Ill from 
BSA-LKT. and RPMI-LKT /BSA were assayed for toxicity against equine 
peripheral blood leukocytes {equine WBC), using BL-3 cells as positive 
controls. Equine WBC were isolated as previously described {5). Equine 
leukocytes suspended in RPM I {2 x 1 0 6 cells/well) were exposed to LKT 
form Peaks I, II, and Ill in 200 ul final volume for 2 hours at 37°C, and the 
supernatant assayed for LDH content as described above. Positive controls 
were the BL-3 cells + CF, BL-3 cells + 1% Triton, and equine WBC + 1% 
Triton. Negative controls were BL-3 cells + RPMI, and equine WBC + 
RPMI. 
MAB neutralization of LKT activity. The susceptibility of LKT from 
Peaks I, II, and Ill from BSA-LKT and RPMI-LKT/BSA to neutralization by an 
anti-LKT MAB (MAB601) was tested by exposing BL-3 cells {4x 105 cells/ 
well) to LKT column fractions preincubated with or without anti-LKT MAB. 
The MAB was decomplemented by heating to 56°C for 1 hour in a water 
bath. Decomplemented MAB + CF (CF were diluted 1:2, and the MAB was 
11 
diluted 1 :500) were incubated at 4°c for 30 minutes; BL-3 cells were then 
added to each well, incubated at 37°C for 2 hours, centrifuged as 
described, and the supernatant assayed for LDH content. Controls were 
MAB + BL-3 cells, Triton 1 % + BL-3 cells, and BL-3 cells + RPMI. 
RESULTS 
Enhanced leukotoxin activity in RPMI growth medium supplemented 
with bovine serum albumin. Logarithmic phase P. haemolytica cultures (0 
to < 6 hours) grown in RPM I medium supplemented with 0. 5% BSA, 
contained 30,700 ± 12,900 TU/ml (mean ± standard deviation) of LKT 
activity, which was significantly greater (P < 0.05) than the 120 ± 40 
TU/ml of LKT activity contained in cultures grown without BSA. In 
contrast, LKT activity (measured in TU) in stationary phase cultures (t ~ 6 
hours) was not significantly different between the two media (P>0.05) 
(Figure 1 ). P. haemolytica growth was quantitatively better in RPMI-BSA 
medium during the logarithmic growth period, compared to growth in RPMI 
(P < 0.05); however, qualitatively the growth curves of P. haemolytica 
grown in RPM I and RPMI-BSA were similar (Figure 1). During stationary 
growth (6-24 hours), the difference in the growth curve was no longer 
significant. Growth of P. haemolytica in media containing BSA significantly 
enhances LKT activity. 
In another experiment, addition of 0.5% BSA directly to logarithmic 
growth phase culture filtrates from RPMI media (RPMI-LKT/BSA) resulted in 
a significant increase (P < 0.05) in LKT activity (Figure 2). At time 0, 
RPMI-LKT/BSA contained 6X more LKT activity than RPMI-LKT, whereas 
BSA-LKT contained 4-5X more activity than RPMI-LKT/BSA, and 25X more 
LKT activity than RPMI-LKT; the difference in LKT activity was significantly 
different between all three (P < 0.05). Activity of BSA-LKT, RPMI-LKT and 
RPMI-LKT/BSA incubated at 25°C was significantly reduced by 120 
12 
Figure 1. Enhanced LKT activity in cultures grown in medium 
containing BSA. (A) During logarithmic growth (0 < t < 6 
hours), culture supernate from P. haemolytica grown in 
RPMI medium without BSA had 120 ± 40 TU/ml, 
whereas (8) supernate from cultures grown in RPMI 
medium containing 0.5% BSA had 30,700 ± 13,000 
TU/ml. (Open diamonds = bacterial growth, Solid 
diamonds = LKT activity) 
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Figure 2. Enhanced LKT activity by addition of BSA to RPMI-LKT 
culture supernate. At t = 0, RPMI-LKT/BSA had 13,000 
± 1 ,600 TU/ml of LKT activity, compared to BSA-LKT 
which had 55,600 ± 11,500 TU/ml and RPMI-LKT 
which had 2,200 ± 900 TU/ml. At t = 120 minutes, 
activity of all three had reduced, however, the reduction 
in activity was more pronounced for RPMI-LKT. (Dia-
monds = BSA-LKT; Triangles = RPMI-LKT/BSA; 
Squares = RPMI-LKT) 
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minutes, compared to initial activity at time 0 (P<0.05), but the reduction 
in LKT activity was most apparent for the RPMI-LKT. Activity of BSA-LKT, 
RPMI-LKT and RPMI-LKT/BSA between 0 and 60 minutes was not statisti-
cally reduced (Figure 2). To make sure that endotoxin levels associated 
with the BSA preparation were not responsible for the apparent increase in 
LKT activity, the experiment was repeated using low endotoxin BSA, and 
the same results were obtained with BSA-LKT, RPMI-LKT and RPMI-
LKT/BSA for each time point (data not shown). Therefore, it appears that 
BSA can act directly on LKT to enhance activity. 
BSA enhanced LKT activity is associated with generation of multiple 
molecular forms. Gel filtration of ammonium sulfate concentrated RPMI-
LKT obtained at 2.5 and 6 hours of incubation (Figures 3a & 3c) or stircell 
concentrated RPMI-LKT obtained at 2.5 hours of incubation (Table 1) 
resulted in the detection of a single activity peak, which corresponded to a 
molecular weight > > 669,000, whereas gel filtration of BSA-LKT obtained 
at both 2.5 and 6 hours of incubation resulted in recovery of three activity 
peaks (Figures 3b & 3d). The percentage of LKT activity from BSA-LKT 
shifted from the higher molecular weight peak to apparent lower molecular 
weight peaks with increased time of incubation of the P. haemolytica 
cultures (Table 1 ). Addition of 0.5% BSA directly to culture filtrate from 
RPMI-LKT (RPMI-LKT/BSA) resulted in an elution profile similar to BSA-LKT 
(Figure 4, Table 1 ). It appears that RPMI-LKT exists as a single large molec-
ular weight form and that incubation of P. haemolytica in media containing 
BSA or addition of BSA directly to RPMI-LKT results in LKT existing as 
multiple forms. 
Identification of LKT subunit in various molecular forms of LKT: 
Fractions from Peak I from RPMI-LKT and Peaks 1-111 from BSA-LKT contained 
Figure 3. RPMI-LKT and BSA-LKT Elution Profiles derived by gel fil-
tration (Sephacryi-HR 400). RPMI-LKT at 2.5 (A) and 6 
hours (C) of culture incubation had a single, low K 
peak, corresponding to a molecular weight > 669,00d~ 
BSA-LKT at 2.5 (B) and 6 hours (D) of culture incuba-
tion had three peaks, with K values corresponding to 
molecular weights of > 669,ac500 for Peak I, > 65,000 
for Peak II, and < 29,000 for Peak Ill. (Solid line = 
pro.tein ~o.ncentration (00280nm). Triangles = Leuko-
toxm act1v1ty. 
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TABLE 1 : Summary of Kav Values8 and Percent LKT Activityb for Fractionated 
RPMI-LKT, BSA-LKT and RPMI-LKT/BSA on Sephacryl HR-400 Gel 
Filtration Column 
RPMI-LKT 
(AS Cone) 
2.5 hr 
6.0 hr 
RPMI-LKT 
(Stircell Cone) 
2.5 hr 
BSA-LKT 
2.5 hr 
6.0 hr 
RPMI-LKT /BSA 
2.5 hr 
PEAK I 
K (% activity) 
av 
0.01 (1 00%) 
0.06 (100%) 
0.04 (100%) 
0.04 ( 40%) 
0.03 ( 5%) 
0.02 ( 25%) 
PEAK II 
K (% activity) 
av 
0.66 ( 35%) 
0.53 ( 75%) 
0.50 (50%) 
PEAK Ill 
K (% activity) 
av 
0.87 ( 25%) 
0.82 ( 20%) 
0.82 ( 25%) 
8 K represents the fraction of the stationary gel volume which is avail-
able for dfffusion of a given solute species. K = V -V 
~ e o · 
V-V 
where V represents the void volume of the co1Lm0e, Vt represents the total 
volume o¥ the packed bed, and V is the elution volume of a particular solute ( 1), 
in this case, RPMI-LKT, BSA-LKT or RPMI-LKT /BSA. 
bPercent LKT Activity was determined by calculating the area under the 
curve for each peak. 
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Figure 4. The RPMI-LKT/BSA elution profile had three activity peaks, 
with K values corresponding to > 669,000 for Peak I, 
> 65,0SOO for Peak II, and < 29,000 for Peak Ill. Solid 
line. ~ protein concentration (0D280nm). Triangles = LKT 
act1v1ty. 
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multiple protein bands on SDS-PAGE (Figures 5a & 6a). A 97,000 band 
was the prominent band for peak I regardless of the source. This 97,000 
protein was identified as LKT on western blots using the anti-LKT MAB 
(Figure 5b & 6b). Peaks 1-111 from BSA LKT also contained a prominent 
66,000 band, consistant with BSA, which did not react with MAB to LKT 
on western blots (Figure 6b). It is likely that this band is composed primari-
ly of BSA. 
Unconcentrated fractions from Peaks II and Ill from BSA-LKT did not 
contain a readily detected 97,000 band on SDS-PAGE (Figure 6a), however 
a 97,000 protein was barely discernible on western blots (Figure 6b). The 
97,000 protein band was visible in concentrated Peaks II and Ill on western 
blots (Figure 7) and SDS-PAGE. SDS-PAGE and western blots of peaks I, II 
and Ill for RPMI-LKT/BSA were similar to BSA-LKT (Figure 8a & 8b). 
Judging from the band densities, although Peak I contains much higher 
amounts of the 97,000 LKT subunit, it is much less active than Peaks II or 
Ill which contain lower amounts of the 97,000 LKT subunit. Based on K 
av 
values, Peak I (regardless of the source) consisted of a large aggregated 
form of LKT with a molecular weight > > 669,000. The K for Peaks II and 
av 
Ill correspond to molecular weights ~ 65,000 (Peak II) and < 29,000 (Peak 
Ill) (F~ure 9), values less than the LKT subunit weight (97,000), suggesting 
that K may not reflect separation only by molecular size. 
av 
The identity of fractions from Peaks II and Ill were further confirmed 
as LKT by target cell specificity and neutralization with a MAB to LKT. 
Peaks I, II and Ill from BSA-LKT and RPMI-LKT/BSA were cytolytic to 
bovine lymphoma cells but not to equine WBC's (Table 2a). Cytolytic activ-
ity in all three peaks was neutralized by a MAB to LKT (Table 2b), confirm-
ing that Peaks II and Ill as well as Peak I consist of LKT. 
Figure 5. SDS-PAGE and Western Blot from RPMI-LKT. (A) Silver 
stained SDS-PAGE gel of ammonium sulfate precipi-
tated (AS) LKT and Peak I from RPMI-LKT had a 97,000 
protein as the prominent band. (B) Western blot of the 
duplicate SDS-PAGE gel, immunoblotted with MAB605b. 
The prominent band for Peak I and AS LKT was a 
97,000 protein. 
116-gr-
66-
1~ 
66-
45-
36-
29-
24-
25 
--------
RPMI-LKT 
AS 
A 
AS 
B~--~--~------~---
Figure 6. SDS-PAGE and Western blot of unconcentrated fractions 
from BSA-LKT. (A) SDS-PAGE: Peaks I, II and Ill and 
ammonium sulfate precipitated (AS) LKT from BSA-LKT 
contained multiple bands, with the prominent band in 
Peak I being a 97,000 protein; Peaks 1-111 also contained 
a prominent 66,000 protein. (8) Western Blot: the 
prominent band in Peak I was a 97,000 protein. In 
Peaks ll.and Ill the 97,000 protein was barely discerni-
ble, and the 66,000 band did not react with the MAB.· 
The AS BSA-LKT band contained smeared protein 
bands between 97,000 and 43,000. 
--- ~--
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43-
31-
21 
97 
66-
43 
31 
A 
BSA-LKT 
21 B 
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Figure 7. Western blot of pooled fractions from BSA-LKT, Peaks I, II 
and Ill, blotted with MAB601. (A) Pooled, non-concen-
trated fractions from Peaks I, II, and Ill. Peak I con-
tained a prominent 97,000 protein. Peaks II and Ill had 
no visible bands. (B) Pooled, concentrated Peaks I, II 
and Ill. The prominent band in Peaks 1-111 was a 97,000 
protein band. (C) Sup"ernate from TCA precipitated, 
pooled fractions. Peak I had a prominent 97,000 pro-
tein. Peaks II and Ill contained no visible bands. CS 
Culture supernate from BSA-LKT had a prominent 
97,000 band. AS Ammonium sulfate precipitated BSA-
LKT had a smeared protein band between 43,000 and 
97,000. 
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43-
31-
21-
A 
II Ill 
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II Ill 
29 
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II Ill CS AS 
Figure 8. SDS-PAGE and Western Blot of RPMI-LKT/BSA. (A) SDS-
PAGE: ammonium sulfate precipitated (AS) LKT and 
Peak I from RPMI-LKT/BSA had a prominent 97,000 
band,and Peaks I, II and Ill had a 66,000 protein band. 
(B) Western Blot: a 97,000 protein band was present in 
Peak I; Peaks II and Ill had no visible bands. 
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Figure 9. Calibration Curve for Sephacryl HR-400, illustrating the 
relationship between K and molecular weight for 
av Peaks I, II and Ill. The K corresponded to a molecular 
weight > 669,000 for P~ak I, > 65,000 for Peak II, and 
< 29,000 for Peak Ill. 
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Calibration Curve for Sephacryl HR-400 
106 ~~~--------------------~========~ Peak I a. 669 kDa 
b. 440 kDa 
c. 232 kDa 
d. 67 kDa 
e. 29 kDa 
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TABLE 2: Summary of (a) Target Cell Specificity Cytotoxicity Assays and 
(b) Neutralization Assays for Peaks I, II and Ill of Fractionated 
BSA-LKT 
(a} 
% Specific Releases 
(Equine WBC} 
Control 
% Specific Releases 
(BL-3 cells} 
(b) 
% Specific Releases ( + MAB601} 
Control 
% Specific Releases 
(-MAB601} 
PEAK I 
0.0 ± 0.0 
58.8 ± 8.1 
0.0 ± 0.0 
65.6 ± 7.2 
PEAK II PEAK Ill 
0.0 ± 0.0 3.6 ± 1.5 
49.9 ± 6.9 42.6 ± 6.8 
0.1 ± 0.14 0.8 ± 0.6 
70.0 ± 4.6 42.6 ± 5.5 
8 %Specific release (mean ± standard deviation} = 
( X LDH release BL-3 cells or Equine WBC - Spontaneous LDH release BL-3 cells or Equine WBC) x 100 
(Maximum LDH release BL-3 cells or Equine WBC - Spontaneous LDH release Bl-3 cells or Equine WBC) 
34 
All test values had P < 0.05 as compared with results with control BL-3 
cells (a} or control BL-3 cells - MAB (b). 
DISCUSSION 
Native LKT produced by P. haemolytica cultures grown in RPMI 
medium appears to be a large aggregate form with low activity. Previous 
studies have attempted to purify native LKT and determine its molecular 
weight. Our findings are in agreement with previous studies which found 
that LKT is a large protein with a molecular weight > 150,000 ( 14, 18) by 
gel filtration and > 300,000 molecular weight by ultrafiltration (2). Recent-
ly, the E. coli a-hemolysin, a genetically related toxin, has been s·hown to 
exist in the form of large aggregates, held together by hydrophobic forces, 
and that the large aggregate form is relatively inactive ( 19). 
Disaggregation of the native large aggregated £. coli a-hemolysin 
increases its activity ( 19). Treatment of a-hemolysin with chaotropic 
agents, such as urea, increase the cytolytic activity and decreases the size 
of the aggrergates, possibly by disruption of the hydrophobic forces which 
would otherwise force the toxin into the aggregated form (19). Our study 
indicates that a similar phenomenon may be occurring with the P. haemolyt-
ica LKT. BSA added directly to the RPMI-LKT may change the environment 
of the LKT such that the native molecule becomes more amphipathic and 
disaggregates, enhancing toxic activity and producing multiple molecular 
toxin forms on gel filtration. In addition to enhancing the activity of LKT, 
BSA probably enhances production of the LKT by P. haemolytica grown in 
RPMI-BSA. BSA-LKT had significantly higher LKT activity than either RPMI-
LKTIBSA or RPMI-LKT. BSA may be causing other changes in the toxin as 
well. By changing the hydrophobicity of the native molecule, it may 
35 
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enhance the native toxin's affinity for the column matrix, causing it to 
chromatograph on the gel filtration column, thus explaining why Peak Ill 
elutes at less than 29,000 on gel filtration, yet contains a 97,000 protein 
band on western blots. 
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